Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells.
about
Clinical application of adoptive T cell therapy in solid tumorsEngineered T cells for cancer treatmentThe promise and potential pitfalls of chimeric antigen receptors.Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma.Genetic redirection of T cells for cancer therapy.
P2860
Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antitumor activity of chimeric ...... expressing colon cancer cells.
@en
type
label
Antitumor activity of chimeric ...... expressing colon cancer cells.
@en
prefLabel
Antitumor activity of chimeric ...... expressing colon cancer cells.
@en
P2093
P2860
P1433
P1476
Antitumor activity of chimeric ...... expressing colon cancer cells.
@en
P2093
Hiroaki Ikeda
Hiroyuki Abe
Masafumi Onodera
Masahide Kuroki
Masaki Miyamoto
Masayoshi Sato
Satoshi Kondo
Takashi Nishimura
Takayuki Ohkuri
Takeshi Sasaki
P2860
P304
P356
10.1111/J.1349-7006.2006.00271.X
P577
2006-07-13T00:00:00Z